#1 Clinical Trials Search in Europe

Vitamin A Bp

This article discusses the use of Vitamin A BP, a component of multivitamin formulations, in clinical trials related to cardiovascular health. Specifically, we’ll explore its potential role in a study focusing on transthyretin-mediated amyloid cardiomyopathy (ATTR-CM), a rare heart condition. While Vitamin A BP is not the primary focus of the trial, it is included in a multivitamin supplement that participants are required to take during the study.

Table of Contents

What is Vitamin A BP?

Vitamin A BP is an essential nutrient that plays a crucial role in various bodily functions. The “BP” in its name stands for “British Pharmacopoeia,” which indicates that it meets specific quality standards[1]. Vitamin A is also known by other names, including retinol, retinal, and retinoic acid, depending on its form.

Uses of Vitamin A BP

Vitamin A BP is an important component in multivitamin formulations. It is used to prevent and treat vitamin A deficiency, which can lead to various health issues. Some of the key functions and benefits of Vitamin A include:

  • Vision support: Vitamin A is essential for maintaining good eyesight, especially in low light conditions.
  • Immune system function: It helps strengthen the body’s natural defenses against infections and diseases.
  • Skin health: Vitamin A supports the growth and maintenance of healthy skin cells.
  • Reproductive health: It plays a role in maintaining reproductive function in both men and women.
  • Growth and development: Vitamin A is crucial for proper growth and development, especially in children.

Formulation and Administration

In the context of the clinical trial information provided, Vitamin A BP is part of a multivitamin formulation called Concavit Capsules[1]. These capsules are designed for oral use, which means they are to be taken by mouth. The specific formulation is described as a soft capsule, which is typically easier to swallow than hard tablets.

Dosage Information

While the exact dosage of Vitamin A BP in Concavit Capsules is not specified, the clinical trial data provides some general information about the dosing:

  • Maximum daily dose: The maximum daily dose is listed as 3000 IU (International Units)[1]. This likely refers to the total amount of vitamins in the capsule, not just Vitamin A.
  • Maximum total dose: The maximum total dose over the course of treatment is listed as 3,285,000 IU[1].
  • Treatment duration: The maximum treatment period is listed as 36 months (3 years)[1].

It’s important to note that these dosage details are specific to the clinical trial and may not reflect general recommendations for Vitamin A supplementation. Always follow your healthcare provider’s instructions regarding vitamin supplementation.

Other Ingredients in Concavit Capsules

Concavit Capsules contain several other vitamins and nutrients in addition to Vitamin A BP. These include:

  • Ergocalciferol BP: Also known as Vitamin D2, it helps with calcium absorption and bone health.
  • Nicotinamide BP: A form of Vitamin B3, important for energy metabolism.
  • Riboflavin BP: Also called Vitamin B2, it’s crucial for energy production and cellular function.
  • All-rac-alpha-tocopheryl acetate BP: A form of Vitamin E, which acts as an antioxidant.
  • Calcium pantothenate BP: Also known as Vitamin B5, it’s important for metabolism and hormone synthesis.
  • Thiamine nitrate BP: A form of Vitamin B1, essential for energy metabolism and nerve function.
  • Ascorbic acid BP: Also known as Vitamin C, it’s an important antioxidant and supports immune function.
  • Pyridoxine hydrochloride BP: A form of Vitamin B6, crucial for protein metabolism and red blood cell formation.

Precautions and Considerations

While Vitamin A is essential for health, it’s important to consider the following:

  • Vitamin A supplementation: The clinical trial data mentions a willingness to adhere to vitamin A supplementation as per protocol[1]. This suggests that careful monitoring of vitamin A intake is important during treatment.
  • Potential interactions: As Concavit Capsules contain multiple vitamins, they may interact with other medications or supplements. Always inform your healthcare provider about all medications and supplements you’re taking.
  • Not for specific disease treatment: While this multivitamin formulation is being used in a clinical trial, it’s important to note that it’s not specifically designed to treat any particular disease. The trial appears to be focused on a different medication (eplontersen) for treating a condition called transthyretin-mediated amyloid cardiomyopathy (ATTR-CM)[1].

As with any supplement or medication, it’s crucial to consult with a healthcare professional before starting or changing your vitamin regimen, especially if you have any underlying health conditions or are taking other medications.

Aspect Details
Study Type Open-Label Extension Study
Main Condition Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM)
Primary Drug Eplontersen
Vitamin A BP Role Part of required multivitamin supplement (Concavit Capsules)
Max Daily Dose of Vitamin A 3000 IU
Administration Route Oral Use
Max Treatment Period 36 months
Key Requirement Adherence to vitamin A supplementation protocol

FAQ

  • What is the main purpose of the clinical trial involving Vitamin A BP? The main purpose of the clinical trial is to evaluate the long-term safety and efficacy of a drug called eplontersen in patients with transthyretin-mediated amyloid cardiomyopathy (ATTR-CM). Vitamin A BP is included as part of a multivitamin supplement that participants are required to take during the study.
  • How is Vitamin A BP administered in this clinical trial? Vitamin A BP is administered as part of a multivitamin capsule called Concavit Capsules. These capsules are taken orally and contain various vitamins and minerals, including Vitamin A BP.
  • What is the maximum daily dose of Vitamin A in the trial? The maximum daily dose of Vitamin A in the trial is 3000 IU (international units).
  • How long does the treatment period last in this clinical trial? The maximum treatment period for this clinical trial is 36 months (3 years).
  • Are there any specific requirements for participants regarding Vitamin A supplementation? Yes, one of the inclusion criteria for the study is the willingness to adhere to vitamin A supplementation as per the study protocol. This suggests that maintaining consistent Vitamin A intake is important for the study.

Ongoing Clinical Trials on Vitamin A Bp

  • Study on Long-Term Safety of Eplontersen for Adults with Transthyretin-Mediated Amyloid Cardiomyopathy

    Recruiting

    1 1 1 1
    Investigated drugs:
    Austria Belgium Czechia Denmark France Germany +6

Glossary

  • Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR-CM): A rare heart condition where abnormal proteins called amyloids build up in the heart, affecting its function and potentially leading to heart failure.
  • Eplontersen: The main drug being studied in this clinical trial for its potential to treat ATTR-CM.
  • Open-Label Extension Study: A type of clinical trial where both the researchers and participants know which treatment is being given, often following a previous study to gather more long-term data.
  • Vitamin A BP: A form of Vitamin A that meets British Pharmacopoeia (BP) standards, included in the multivitamin supplement used in this study.
  • IU (International Unit): A measurement used for vitamins and other biological substances, based on their biological activity or effect.
  • Multivitamin: A supplement containing various vitamins and sometimes minerals, designed to provide a range of essential nutrients.
  • Oral Use: A method of taking medication or supplements by mouth, typically in the form of pills, capsules, or liquids.

References

  1. http://clinicaltrials.eu/trial/study-on-long-term-safety-of-eplontersen-for-adults-with-transthyretin-mediated-amyloid-cardiomyopathy/